Blog

Our Carboxygenator in the spotlight!

Ever wondered how our carboxygenator precisely works within the Osilaris™?

We get that question more often, so today we’re excited to share the science behind it, step by step.

Ask the Expert: PhD Student Javier Olmos Becerra on HEK293T culture using Osilaris™

Javier Olmos Becerra has been working on optimizing HEK293T expansion in the Osilaris™, with a focus on point-of-care CAR T cell production. Read along for his insights!

HEK293T Cell Line as a Platform for Producing Viral Vectors for Gene Therapy

HEK293T cells, derived from human embryonic kidney cells, are especially suitable for generating lentiviral (LV) vectors, which makes them a valuable tool for CAR T cell therapy production and other advanced therapeutic applications.

Organoid Culture: The potential to revolutionize disease modeling

Organoids have emerged as a revolutionary tool in drug discovery and clinical practice. These miniature 3D structures, cultivated from stem cells or differentiated cells, mimic the architecture and function of organs, offering a significant advancement over traditional cell culture methods.

Ask the Expert: Process Development Engineer Juda-El Sam on iPSC culture using Osilaris™

To standardize iPSC differentiation and production to a level necessary for producing therapy grade cells, Process Development Engineer Juda-El Sam from Scinus Cell Expansion is working on developing protocols for iPSC expansion using the Osilaris™ system.

iPSCs for personalized cell therapy: Prospects and remaining challenges

The unique nature of induced pluripotent stem cells (iPSCs) lies in their capability for unlimited self–renewal and programmed differentiation into virtually any adult cell types. iPSC based technology holds the potential to treat a multitude of diseases and conditions.